The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Yield
-
Dividend safety
N/A
Growth score
N/A
Dividend growth last 5 y.
-7% / year
Market Cap
36 million
PE Ratio
16.46 x
Beta (volatility)
-0.06
Earnings Per Share
2.43
About
ISIN : US09065J1016
provides research, development, pre-clinical, and testing/assay services to commercial and government clients in the United States.
The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and...
Price
Performance Comparison
| Bioqual Inc | |
|---|---|
| 1 year return |
-42 %
|
| 5 years return |
-51 %
|
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 1.57 | 15 % | 0.00 |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| 0.74 | 12.71 | 0.04 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
Uninter. Dividend
11 years
Frequency
1x / year
Dividends in 2024
October
Dividends in 2023
October
October
Dividends in 2023
October
Forward Annual Amount
$0.00
Ex-dividend
10/7/2024
Number of Outstanding Shares
Financials
Year-over-Year growth
Profitability
Health
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2025 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.